A recurrent mutation in PARK2 is associated with familial lung cancer.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  American Journal of Human Genetics

• Publication date

  2015-02-05

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.ajhg.2014.12.016PMID 25640678PMCID PMC4320264
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pan-cancer genetic analysis identifies PARK2 as a master regulator of G1/S cyclins

  2014cited by this paper
• PARK2 orchestrates cyclins to avoid cancer

  2014cited by this paper
• Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer

  2014cited by this paper
• An emerging role of PARK2 in cancer

  2013cited by this paper
• VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing.

  2012cited by this paper
• Exome sequencing identifies MXRA5 as a novel cancer gene frequently mutated in non-small cell lung carcinoma from Chinese patients.

  2012cited by this paper
• The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data.

  2012cited by this paper
• A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma

  2011cited by this paper
• Epidemiology and etiology of Parkinson’s disease: a review of the evidence

  2011cited by this paper
• A genome-wide association study identifies two new lung cancer susceptibility loci at 13q12.12 and 22q12.2 in Han Chinese

  2011cited by this paper
• Global cancer statistics

  2011cited by this paper
• The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data.

  2010cited by this paper
• A susceptibility locus on chromosome 6q greatly increases lung cancer risk among light and never smokers.

  2010cited by this paper
• Somatic mutations of the Parkinson's disease–associated gene PARK2 in glioblastoma and other human malignancies

  2010cited by this paper
• ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data

  2010cited by this paper
• Fine Mapping of Chromosome 6q23-25 Region in Familial Lung Cancer Families Reveals RGS17 as a Likely Candidate Gene

  2009cited by this paper
• Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1

  2008cited by this paper
• Common 5p15.33 and 6p21.33 variants influence lung cancer risk

  2008cited by this paper
• A variant associated with nicotine dependence, lung cancer and peripheral arterial disease

  2008cited by this paper
• A Prospective Cohort Study of Cancer Incidence Following the Diagnosis of Parkinson's Disease

  2007cited by this paper
• Familial-associated mutations differentially disrupt the solubility, localization, binding and ubiquitination properties of parkin.

  2005cited by this paper
• Atypical cancer pattern in patients with Parkinson's disease

  2004cited by this paper
• RING finger 1 mutations in Parkin produce altered localization of the protein.

  2003cited by this paper
• Parkin protects against the toxicity associated with mutant alpha-synuclein: proteasome dysfunction selectively affects catecholaminergic neurons.

  2002cited by this paper
• Parkin Protects against the Toxicity Associated with Mutant α-Synuclein: Proteasome Dysfunction Selectively Affects Catecholaminergic Neurons

  2002cited by this paper
• A meta‐analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease

  2002cited by this paper
• Impairment of the ubiquitin‐proteasome system causes dopaminergic cell death and inclusion body formation in ventral mesencephalic cultures

  2002cited by this paper
• Impairment of the ubiquitin-proteasome system by protein aggregation.

  2001cited by this paper
• Association between early-onset Parkinson's disease and mutations in the parkin gene.

  2000cited by this paper
• Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism

  1998cited by this paper
• Occurrence of different cancers in patients with Parkinson's disease

  1995cited by this paper
• Young onset Parkinson's disease

  1987cited by this paper
• A retrospective study of smoking in Parkinson's disease.

  1968cited by this paper
• BIOINFORMATICS ORIGINAL PAPER

  year unknowncited by this paper

• Advances in the Basic Sciences in Thoracic Oncology in the Last 20 Years and Their Translational Impact.

  2026cites this paper
• Comprehensive genomic profiling of Chinese lung cancer characterizes germline-somatic mutation interactions influencing cancer risk

  2025cites this paper
• Germline Mutation Analysis and Real-World Impact in a Selected Cohort of Patients with Non-Small Cell Lung Cancer: INHERITY LC Study.

  2025cites this paper
• High penetrance rare variants underlying familial lung cancer risk: Insights from genetic epidemiology of lung cancer consortium.

  2025cites this paper
• Parkin inhibits proliferation and migration of bladder cancer via ubiquitinating Catalase

  2024cites this paper
• Iron chelators as mitophagy agents: Potential and limitations.

  2024cites this paper
• Deficiency in the mitophagy mediator Parkin accelerates murine skin allograft rejection.

  2024cites this paper
• Facing an un-met need in lung cancer screening: the never smokers.

  2024cites this paper
• Biological and therapeutic implications of the cancer-related germline mutation landscape in lung cancer.

  2024cites this paper
• A rare FGF5 candidate variant (rs112475347) for predisposition to nonsquamous, nonsmall‐cell lung cancer

  2023cites this paper
• Comprehensive molecular characterization of adenoid cystic carcinoma reveals tumor suppressors as novel drivers and prognostic biomarkers

  2023cites this paper
• Pathogenic germline variants in BRCA1 and TP53 increase lung cancer risk in Chinese

  2023cites this paper
• Sporadic pituitary adenoma with somatic double-hit loss of MEN1

  2023cites this paper
• Unravelling the genetic links between Parkinson’s disease and lung cancer

  2023cites this paper
• Invited editorial: Q and A on hereditary lung cancer.

  2022cites this paper
• The RING finger protein family in health and disease

  2022influential citation
• Deep-LC: A Novel Deep Learning Method of Identifying Non-Small Cell Lung Cancer-Related Genes

  2022cites this paper
• Integrated genomic analyses of acral and mucosal melanomas nominate novel driver genes

  2022cites this paper
• Germline Pathogenic Variants Impact Clinicopathology of Advanced Lung Cancer.

  2022cites this paper
• Parkin: A targetable linchpin in human malignancies.

  2021cites this paper
• Cancer in Parkinson’s Disease: An Approximation to the Main Risk Factors

  2021cites this paper
• Duo Shared Genomic Segment analysis identifies a genome-wide significant risk locus at 18q21.33 in myeloma pedigrees

  2021cites this paper
• Comprehensive Genomic and Transcriptomic Analysis of Three Synchronous Primary Tumours and a Recurrence from a Head and Neck Cancer Patient

  2021cites this paper
• Germline ERBB3 mutation in familial non-small-cell lung carcinoma: expanding ErbB’s role in oncogenesis

  2021cites this paper
• Profiling Oncogenic Germline Mutations in Unselected Chinese Lung Cancer Patients

  2021cites this paper
• Rare deleterious germline variants and risk of lung cancer

  2021cites this paper
• Exploring market overreaction, investors’ sentiments and investment decisions in an emerging stock market

  2020cites this paper
• RBR E3 ubiquitin ligases in tumorigenesis.

  2020cites this paper
• Targeting lung cancer screening to individuals at greatest risk: the role of genetic factors

  2020cites this paper
• The contribution of hereditary cancer-related germline mutations to lung cancer susceptibility

  2020influential citation
• Germline ERBB3 mutation in familial non-small cell lung carcinoma: expanding the role of the ErbB family in oncogenesis

  2020cites this paper
• A Systematic Literature Review of Whole Exome and Genome Sequencing Population Studies of Genetic Susceptibility to Cancer

  2020cites this paper
• Cepharanthine hydrochloride induces mitophagy targeting GPR30 in hepatocellular carcinoma (HCC)

  2020cites this paper
• Whole exome sequencing in familial isolated primary hyperparathyroidism

  2019cites this paper
• Germline mutations in lung cancer.

  2019cites this paper
• The inherited variations of a p53-responsive enhancer in 13q12.12 confer lung cancer risk by attenuating TNFRSF19 expression

  2019cites this paper
• Somatic and germline mutations in the tumor suppressor gene PARK2 impair PINK1/Parkin-mediated mitophagy in lung cancer cells

  2019cites this paper
• PARK2 Suppresses Proliferation and Tumorigenicity in Non-small Cell Lung Cancer

  2019cites this paper
• PARK2 inhibits osteosarcoma cell growth through the JAK2/STAT3/VEGF signaling pathway

  2018cites this paper
• Immunogenomic Landscape Contributes to Hyperprogressive Disease after Anti-PD-1 Immunotherapy for Cancer

  2018cites this paper
• HSP90-incorporating chaperome networks as biosensor for disease-related pathways in patient-specific midbrain dopamine neurons

  2018cites this paper
• Inherited lung cancer syndromes targeting never smokers.

  2018cites this paper
• Germline mutations in young non-smoking women with lung adenocarcinoma.

  2018cites this paper
• Rare Variants in Known Susceptibility Loci and Their Contribution to Risk of Lung Cancer

  2018cites this paper
• Genome-wide association study of familial lung cancer

  2018cites this paper
• PRKN (arkin RBR E3 ubiquitin protein ligase )

  2018cites this paper
• Hereditary Lung Cancer Risk: Recent Discoveries and Implications for Genetic Counseling and Testing

  2018cites this paper
• A Decade of GWAS Results in Lung Cancer

  2017cites this paper
• Familial Lung Cancer: A Brief History from the Earliest Work to the Most Recent Studies

  2017cites this paper
• Inactivation of parkin by promoter methylation correlated with lymph node metastasis and genomic instability in nasopharyngeal carcinoma

  2017cites this paper
• Genetic susceptibility variants for lung cancer: replication study and assessment as expression quantitative trait loci

  2017cites this paper
• Screening and Early Detection of Lung Cancer.

  2017cites this paper
• Identification of novel risk variants for sarcoma and other cancers by whole exome sequencing analysis in cancer cluster families

  2017cites this paper
• Germline Mutations in DNA Repair Genes in Lung Adenocarcinoma

  2017cites this paper
• RING-, HECT-, and RBR-type E3 Ubiquitin Ligases: Involvement in Human Cancer.

  2016cites this paper
• Risk Factors for Lung Cancer in Never Smokers: A Recent Review Including Genetics

  2016cites this paper
• Increased risk of brain tumor in patients with Parkinson's disease: a nationwide cohort study in Taiwan

  2016cites this paper
• Parkin Alternative Splicing : Not only Parkinsonism

  2016cites this paper
• Multiple-level validation identifies PARK2 in the development of lung cancer and chronic obstructive pulmonary disease

  2016cites this paper
• An Overview of Genetic Polymorphism and Lung Cancer Risk

  2016cites this paper
• Parkin Somatic Mutations Link Melanoma and Parkinson's Disease.

  2016cites this paper
• Pan-Cancer Analysis Links PARK2 to BCL-XL-Dependent Control of Apoptosis

  2016cites this paper
• Cell-free DNA and next-generation sequencing in the service of personalized medicine for lung cancer

  2016cites this paper
• Risk of lung cancer in Parkinson's disease

  2016cites this paper
• Dysregulation of ubiquitin ligases in cancer.

  2015cites this paper
• Identification of novel hereditary cancer genes by whole exome sequencing.

  2015cites this paper
• Association Between Parkinson Disease and Risk of Cancer in Taiwan.

  2015cites this paper
• PARK2 gene and familial lung cancer: what is the link?

  2015cites this paper
• Cancer associated missense mutations in BAP1 catalytic domain induce amyloidogenic aggregation: A new insight in enzymatic inactivation

  2015cites this paper
• Next generation sequencing technologies in cancer diagnostics and therapeutics: A mini review.

  2015cites this paper